BRIEF-Repatha receives European commission approval for new 420 mg single-dose delivery option
February 21, 2017 at 16:24 PM EST
* Repatha (evolocumab) receives european commission approval for new 420 mg single-dose delivery option Source text for Eikon: Further company coverage:
